The pre-clinical results must be outstanding, therefore full steam ahead for the clinical trials. Nothing left to chance here, success highly likely as the best of the world in that field are in charge.
GLTA
Ann: Strategic manufacturing partnership with WuXi ATU, page-2
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.18M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.7¢ | 1.6¢ | $2.101K | 127.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 1919476 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 328619 | 3 |
View Market Depth
| Last trade - 15.32pm 29/08/2024 (20 minute delay) ? |
| CHM (ASX) Chart |